Does Spironolactone Decrease Free Testosterone Levels in Women?
Yes, spironolactone lowers total testosterone levels in women with hirsutism, but its effect on free testosterone is inconsistent and may paradoxically increase free testosterone in some cases despite clinical improvement.
Mechanism and Expected Effects
Spironolactone exerts anti-androgenic effects through multiple pathways 1:
- Peripheral androgen receptor blockade – the primary mechanism of clinical benefit 2
- Decreased ovarian androgen production when combined with oral contraceptives 1
- Altered testosterone metabolism and reduced blood production rate 3
The FDA label confirms spironolactone has known anti-androgenic activity, which is the basis for avoiding it in pregnancy due to potential feminization of male fetuses 4.
Clinical Evidence on Free Testosterone
Paradoxical Free Testosterone Changes
The most rigorous data show spironolactone may not reliably lower free testosterone and can produce counterintuitive results:
In a controlled study of hirsute women, unbound (free) testosterone remained unaltered despite significant decreases in total testosterone with both 100 mg and 200 mg daily doses over 3 months 2
A dedicated study of testosterone fractions found that after 3 months of spironolactone 100 mg twice daily, there was a shift toward increased free and albumin-bound testosterone (the bioavailable fractions), with decreased SHBG-bound testosterone 5
This redistribution occurred despite clinical improvement in hirsutism, suggesting the peripheral receptor blockade is more important than serum androgen levels 5
Total Testosterone Reduction
When combined with oral contraceptives, spironolactone consistently reduces total testosterone:
Spironolactone 100 mg daily plus oral contraceptives resulted in significant reduction in serum total testosterone, free testosterone, and percentage of free testosterone in 16 hirsute women 6
Low-dose spironolactone (50 mg daily) decreased total and free testosterone concentrations when given cyclically (days 4-22) over 12 months 7
Critical Clinical Implications
The lack of consistent free testosterone suppression does not predict clinical failure 2, 5:
- Hair shaft diameter decreased significantly (19-30%) with spironolactone despite unchanged free testosterone 2
- No correlation was found between hair growth improvement and serum androgen levels 2
- Approximately 80% of hirsute women showed good to very good clinical results with spironolactone therapy 3
Practical Recommendations
When to Use Spironolactone
- First-line combination: Oral contraceptives for ≥6 months, then add spironolactone 100-200 mg daily if hirsutism persists 1
- Dosing: 100-200 mg daily divided into two doses 1
- Duration: Minimum 12 months required to assess treatment response 1
Monitoring Considerations
- Do not rely on free testosterone levels to guide spironolactone therapy or predict clinical response 2, 5
- Testosterone fraction studies are not clinically useful parameters in women receiving anti-androgen therapy 5
- Clinical assessment of hirsutism (modified Ferriman-Gallwey score) is more reliable than biochemical markers 1
Mandatory Precautions
- Strict contraception is mandatory due to teratogenic risk from anti-androgenic effects 1, 4
- Monitor serum potassium and renal function before initiating therapy 1
- Never use as monotherapy without effective contraception 1
Key Pitfall to Avoid
Do not discontinue or adjust spironolactone based on free testosterone levels that fail to decrease or paradoxically increase – the peripheral anti-androgenic effect at the receptor level is responsible for clinical benefit, not the serum androgen concentration 2, 5, 3.